State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 178 actively recruiting studies with Utah sites out of 178 registered in total. The busiest research areas in Utah are Malignant Neoplasm, Advanced Solid Tumor, Heart Failure. Leading sponsors running trials in the state include University of Utah, Eli Lilly and Company, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (30), Phase 2 (47), Phase 3 (49), Phase 4 (6).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Malignant Neoplasm (3)Advanced Solid Tumor (3)Heart Failure (3)Heart Diseases (3)Cardiovascular Diseases (3)Pulmonary Hypertension (3)Non-Small Cell Lung Cancer (3)Alopecia Areata (2)B Acute Lymphoblastic Leukemia (2)Treatment Resistant Depression (2)Pancreatic Ductal Adenocarcinoma (2)Ischemic Stroke (2)
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Malignant Neoplasm, Advanced Solid Tumor, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT06917911 Phase 2
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatm...
Condition
Core Binding Factor Acute Myeloid Leukemia
Enrollment
162 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
1,330 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT07194044 Phase 1
Recruiting
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Condition
Metastatic Ewing Sarcoma
Enrollment
15 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT05059444 N/A
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Condition
Bladder Carcinoma
Enrollment
2,285 pts
Location
United States, France, Germany
Sponsor
Guardant Health, Inc.
NCT05283811 N/A
Recruiting
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic C...
Condition
Epilepsy
Enrollment
205 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT05848687 Phase 1, Phase 2
Recruiting
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition
Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Canada
Sponsor
Tanja Andrea Gruber
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
NCT07094087 Phase 3
Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adul...
Condition
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Enrollment
200 pts
Location
United States, Canada, Japan
Sponsor
CSL Behring
NCT07223047 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone a...
Condition
Advanced Solid Malignancies
Enrollment
252 pts
Location
United States, Canada, Spain
Sponsor
Bristol-Myers Squibb
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT07601074 Phase 2
Recruiting
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Hu...
Condition
Human Papilloma Virus (HPV)
Enrollment
118 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
NCT06911138 N/A
Recruiting
Treating Complex Grammar Knowledge Deficits in School-Age Children With Developm...
Condition
Developmental Language Disorders
Enrollment
150 pts
Location
United States
Sponsor
Ohio University
NCT07300943 Phase 1, Phase 2
Recruiting
Study in Advanced Solid Tumor Patients
Condition
Advanced Solid Tumor
Enrollment
306 pts
Location
United States, Australia
Sponsor
Callio Therapeutics
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT06223503 N/A
Recruiting
VA Transitional Pain Service Study
Condition
Chronic Opioid Use
Enrollment
400 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06124157 Phase 2
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatme...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
222 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT03556228 Phase 1, Phase 2
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpr...
Condition
Head and Neck Carcinoma
Enrollment
242 pts
Location
United States, Puerto Rico
Sponsor
VM Oncology, LLC
NCT06503367 N/A
Recruiting
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscul...
Condition
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)
Enrollment
44 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05945329 N/A
Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Brea...
Condition
Capsular Contracture Associated With Breast Implant
Enrollment
250 pts
Location
United States
Sponsor
C. R. Bard
NCT00345553 N/A
Recruiting
Biliary Atresia Study in Infants and Children
Condition
Biliary Atresia
Enrollment
1,265 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT07143019 N/A
Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked ...
Condition
Hemorrhagic Stroke
Enrollment
214 pts
Location
United States
Sponsor
phenox Inc.
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology